Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance
Author(s) -
JeanLouis Chiasson,
Robert G. Josse,
Ramón Gomis,
M Hanefeld,
Avraham Karasik,
Markku Laakso,
for The STOP-NIDDM Trial Research Group
Publication year - 2003
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.290.4.486
Subject(s) - medicine , acarbose , impaired glucose tolerance , hazard ratio , postprandial , placebo , heart failure , diabetes mellitus , body mass index , randomized controlled trial , surgery , type 2 diabetes , endocrinology , insulin , confidence interval , alternative medicine , pathology
The worldwide explosive increase in type 2 diabetes mellitus and its cardiovascular morbidity are becoming major health concerns.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom